invasively determined PBV in vitro 4 and in patients undergoing cardiac surgery. 5 PBV is related to left atrial (LA) pressure. 6 Pulmonary artery wedge pressure (PAWP) is a more readily available estimate of LA pressure that is commonly used in clinical practice. If shown to be a reasonable surrogate for PAWP, noninvasively obtained PBV could be useful in the determination of volume status, categorization of pulmonary hypertension subtypes, and in assessing response to therapy (ie, volume administration or diuresis).
Therefore, in a proof-of-concept pilot study, we aimed to assess the relationship between PBV determined by contrast echocardiography and invasively obtained PAWP.
| Theory
Pulmonary blood volume and PTT are related to the cardiac output (CO), the product of stroke volume (SV), and heart rate (HR):
Pulmonary transit time can be normalized by the HR, which produces the normalized PTT (nPTT), a parameter that reports on the number of "beats" (cardiac cycles) needed for the PBV to traverse the pulmonary circulation, rather than the amount of time needed to do so.
Combining Equations (1) and (2) and re-arranging terms yields the following:
The normalized PTT gives the PBV relative to the overall stroke volume (rPBV) and can facilitate serial measurements within a given patient (assessing for changes over time or with an intervention) and could be used for comparisons between patients as well.
Stroke volume can be estimated via standard transthoracic echocardiography (TTE) using the product of the left ventricular outflow tract velocity-time integral (LVOT VTI) and the LVOT area. 7 Therefore, an estimate of absolute PBV can be obtained from rPBV as well. This capability would be particularly useful when performing serial measurements, as it allows determination of which component of rPBV (or both) changed over time or in response to an intervention.
| ME THODS

| Study population
This study was approved by the Vanderbilt Medical Center IRB.
The study population consisted of adult survivors of childhood cancer exposed to chest radiation (St Jude Lifetime Cohort) who underwent comprehensive right-heart catheterization at our institution as part of a definitive evaluation for pulmonary hypertension.
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(1) The study protocol called for those individuals to undergo a standard TTE with echocardiographic contrast on the same day, prior to the catheterization procedure.
Demographic characteristics, anthropomorphic measurements, and medical history were abstracted from the electronic medical record. For consistency, the participant ID numbers from the prior study 8 are maintained (Tables 1-3 ).
| Echocardiography, contrast administration, and PTT measurement
For all participants, a comprehensive echocardiogram was Medical Imaging, Inc., Billerica, Massachusetts) was used for ultrasound contrast administration, as previously described, after exclusion of intracardiac shunting by agitated saline injection. 3 The entry of contrast into the right heart and subsequent appearance in the left heart was recorded in the apical 4-chamber view. These images were analyzed off line using QLab 9. After placement of ROIs, time-intensity curves of contrast passage through the RV and LA were generated by the QLab software.
These curves served as the inputs to our previously described inflection point algorithm, from which PTT is calculated. 
| Invasive hemodynamics via right-heart catheterization
Under sterile conditions, a Swan-Ganz catheter was floated through an introducer placed in the right internal jugular vein using the modi- 
| Normalized PTT and rPBV determination
As described in the Theory section, rPBV (equivalent to nPTT) was Table 1 ). Given that E/e′ is commonly used as an echocardiographic surrogate for PAWP, 13 the ratio of mitral inflow velocity to tissue Doppler velocity was calculated for each participant as well.
| Statistical analysis
Correlation of echocardiographically determined rPBV with invasively determined PAWP was determined using the Spearman correlation coefficient (GraphPad Prism, La Jolla CA, version 7.02). A similar correlation for E/e′ and PAWP was performed as well.
| RE SULTS
This pilot study consisted of patients who were middle-aged and almost uniformly overweight/obese with a similar distribution of men and women (Table 1) . Left ventricular ejection fraction (LVEF) was normal in all participants, and RV dysfunction (defined by abnormal RVFAC) was present in 2 participants.
The RA (normal: <8 mm Hg), mPA (normal: <25 mm Hg), and PAW (normal: <15 mm Hg) pressures ranged from normal to significantly elevated ( Table 2 ). The variability was less for Cardiac Index (Fick method) and mixed venous oxygen saturation. Pulmonary vascular resistance (PVR) varied from <1 to 6 Wood Units (WU; normal:
<1.5 WU).
Pulmonary transit time, rPBV, and absolute PBV are shown in Table 3 , in addition to the elapsed time between the echocardiographic PTT measurement and the beginning of the cardiac catheterization procedure. This interval was <3 hours for all participants. 
| D ISCUSS I ON
In this proof-of-concept pilot study, we estimated PBV from contrast echocardiography and demonstrated a significant correlation with invasively measured left-sided filling pressure. The relationship between noninvasively measured PBV and PAWP in the present study is similar to that found between invasively acquired PBV and direct left atrial pressure. 6 In addition, the absolute values for PBV and PBV indexed to body surface area in the two studies are comparable, particularly among individuals with low filling pressure and low PVR. In the current cohort, E/e′ was not an optimal surrogate for PAWP, suggesting that echocardiographically derived rPBV could potentially serve as an alternative.
Even in the context of a proof-of-concept assessment, this study has several notable limitations. Clearly, the sample size is small, and larger studies are needed to validate these findings. The spectrum of cardiopulmonary disorders represented in this study is relatively narrow, as most participants had pulmonary hypertension, although the range of hemodynamics represented is reasonably broad. The generalizability of these findings to populations without pulmonary hypertension needs to be established. To further assess whether rPBV adds value to established echocardiographic metrics, this technique should be examined in conditions where E/e′ is challenging to interpret (ie, atrial fibrillation, prosthetic mitral valves, constrictive pericarditis, infarction affecting myocardium near the medial, or lateral annulus of the mitral valve).
The use of the apical 4-chamber view to derive rPBV confounds the measurement due to the inclusion of the RV into the flow pathway. Theoretically, this variability could be reduced using the parasternal long-axis view or apical 3-chamber view (ie, the RVOT could be used as the right-sided chamber) or the parasternal shortaxis view at the level of the aortic valve (where the mPA could be used, thus eliminating any portion of the RV), although these options were not tested in the present study. In conclusion, we provide preliminary evidence that PTT obtained from contrast echocardiography can be used to derive rPBV, which correlates with invasive PAWP. If confirmed in subsequent studies, this parameter could be useful in the noninvasive assessment of volume status, distinguishing precapillary from postcapillary pulmonary hypertension, and gauging response to interventions.
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